Valuation : SIGA Technologies, Inc.

Market Cap 226M 194M 182M 166M 313M 21.47B 315M 2.16B 841M 10.89B 847M 829M 36.04B P/E 2026 *
62.8x
P/E 2027 * 2.91x
Enterprise Value 108M 92.62M 86.97M 79.38M 149M 10.24B 150M 1.03B 401M 5.19B 404M 395M 17.19B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 0.48x
Free-Float
57.27%
Yield 2026 *
19.1%
Yield 2027 * 19.1%
1 day+2.61%
1 week+6.80%
Current month-3.98%
1 month-3.98%
3 months-29.28%
6 months-49.52%
Current year-48.61%
1 week 2.91
Extreme 2.91
3.16
1 month 2.83
Extreme 2.83
3.31
Current year 2.83
Extreme 2.83
7.1
1 year 2.83
Extreme 2.83
9.45
3 years 2.83
Extreme 2.83
12.83
5 years 2.83
Extreme 2.83
26.99
10 years 1.9
Extreme 1.9
26.99
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-26
Director of Finance/CFO 55 2011-02-09
Chief Operating Officer - 2019-12-31
Director TitleAgeSince
Director/Board Member 73 2009-03-10
Director/Board Member 72 2020-06-15
Director/Board Member 42 2020-12-09
Date Insider Type Main position Quantity % Market Cap. Importance
3/25/26 Exercice

General Counsel

17,366 0.0243%
3/13/26 Exercice

General Counsel

121,769 0.1700%
3/13/26 Exercice

Chief Technology Officer

81,787 0.1142%
Change 5-day change 1-year change 3-year change Capi.($)
+2.61%+6.80%-63.62%-31.59% 226M
-1.52%-7.23%+57.90%+108.72% 1,031B
-0.82%-2.63%+50.05%+64.43% 641B
+0.37%-3.06%+21.87%+74.48% 453B
-1.91%-6.43%+33.21%+33.15% 349B
+4.61%+1.69%+26.95%+44.33% 290B
-0.13%-1.75%+0.41%+11.59% 252B
-0.59%-3.15%+49.83%+67.70% 232B
+0.20%-2.26%-19.88%-54.08% 201B
+0.45%-0.27%+29.84%+91.34% 181B
Average +0.65%-2.61%+18.65%+41.01% 363B
Weighted average by Cap. +0.42%-3.97%+36.96%+64.98%

Financials

2026 *2027 *
Net sales 59.86M 51.54M 48.4M 44.18M 82.99M 5.7B 83.59M 573M 223M 2.89B 225M 220M 9.56B 162M 140M 131M 120M 225M 15.42B 226M 1.55B 604M 7.82B 608M 595M 25.89B
Net income 3.72M 3.2M 3.01M 2.75M 5.16M 354M 5.19M 35.64M 13.87M 179M 13.97M 13.66M 594M 77.88M 67.06M 62.97M 57.48M 108M 7.41B 109M 746M 290M 3.76B 292M 286M 12.44B
Net Debt -118M -102M -95.43M -87.11M -164M -11.23B -165M -1.13B -440M -5.7B -443M -434M -18.86B -148M -127M -120M -109M -205M -14.07B -207M -1.42B -551M -7.14B -555M -543M -23.63B
Logo SIGA Technologies, Inc.
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Employees
49
Date Price Change Volume
26-08-31 US$3.140 +2.61% 889,211
26-08-28 US$3.060 -.--% 569,084
26-08-27 US$3.060 -0.33% 813,649
26-08-26 US$3.070 +0.99% 651,123
26-08-25 US$3.040 +3.40% 375,047
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SIGA Stock